{"": [95, 103, 0, 104, 1211, 0], "Introduction": [1212, 5414, 0], "Mutations in the LYQD motif change the glycosylation pattern of the SARS-CoV-2\u00a0S protein": [5424, 8096, 0], "611LY612 sequence is required for high titer of Spp production in HEK293T": [8097, 10613, 0], "611LY612 sequence is required for S protein maturation and trafficking": [10614, 12819, 0], "Palmitoylation is required for efficient Spp and SARS-CoV-2 production": [12820, 14595, 0], "SARS-CoV-2\u00a0S protein is palmitoylated at multiple cysteine residues": [14596, 16968, 0], "Palmitoylation targets mature S protein to the Golgi and plasma membrane": [16969, 18473, 0], "S protein palmitoylation is required for the ACE2-mediated cell fusion": [18474, 20199, 0], "Results": [5415, 20199, 1], "Limitations of the study": [25951, 26584, 0], "Discussion": [20200, 26584, 1], "Key resources table": [26599, 26626, 0], "Lead contact": [26650, 26825, 0], "Materials availability": [26826, 26922, 0], "Resource availability": [26627, 26922, 1], "Cell, virus, and reagent": [26963, 28047, 0], "VSV based-SARS-CoV-2\u00a0S pseudovirus (Spp)": [28048, 29215, 0], "Experimental model and subject details": [26923, 29215, 1], "Immunoblotting and PNGase F treatment": [29232, 29954, 0], "Immunofluorescence assay": [29955, 30648, 0], "Flow cytometry": [30649, 31669, 0], "S protein-mediated cell-cell fusion assay": [31670, 32330, 0], "Modified acyl-PEG exchange (APE) to monitor S protein palmitoylation": [32331, 35921, 0], "Cell proliferation assay": [35922, 36434, 0], "Method details": [29216, 36434, 1], "Quantification and statistical analysis": [36435, 36643, 0], "STAR\u2605Methods": [26585, 36643, 1]}